Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
EV/Net Sales

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year EV/Net Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Net Sales(x) 4.113.667.217.334.94

What is the latest EV/Net Sales ratio of NATCO PHARMA ?

The latest EV/Net Sales ratio of NATCO PHARMA is 4.11 based on Mar2024 Consolidated results.
Year EV/Net Sales
Mar20244.11
Mar20233.66
Mar20227.21
Mar20217.33
Mar20204.94

How is EV/Net Sales of NATCO PHARMA Trending?

Years EV/Net Sales % Change
Mar2024 4.11
12.30
Mar2023 3.66
-49.24
Mar2022 7.21
-1.64
Mar2021 7.33
48.38
Mar2020 4.94 -

Other Financial Ratios of NATCO PHARMA


Compare EV/Net Sales ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,809.2 Cr 1% -14.7% -40.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹394,187.0 Cr 0.6% -2.4% -7% Stock Analytics
DIVIS LABORATORIES ₹163,282.0 Cr -0.3% -7.6% 23% Stock Analytics
CIPLA ₹128,619.0 Cr 1.8% 8.1% -0.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹124,712.0 Cr 0.9% 3.7% 8.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,577.0 Cr 1% 2.4% -9.6% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

1%

-14.7%

-40.1%

SENSEX

0.9%

-1.1%

0.6%


You may also like the below Video Courses